The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has given its green light to Zydus Healthcare Limited for the production and sale of Sodium Chloride Nebuliser Solution BP 3% w/v.
Therapeutic monoclonal antibodies (mAbs) have become a cornerstone of modern medicine, particularly in oncology, autoimmune disorders, and infectious diseases
The OneSight EssilorLuxottica Foundation, an international leader in inclusive vision care, has partner with the World Health Organization (WHO) to expand eye health services across NITI Aayog's aspirational blocks.
Neuberg Diagnostics, has added a Wellness Centre and Processing Lab to its list of facilities in Chennai. This new Wellness Centre in Abhiramapuram was inaugurated by Dr. Sengottuvelu G, Senior Consultant and Interventional Cardiologist at Apollo
Biocon Pharma Limited which is its fully controlled subsidiary along with Carnegie Pharmaceuticals LLC has been given approval by the US Food and Drug Administration (USFDA) to file the Abbreviated New Drug Application
Eli Lilly announced a $1 billion investment in Telangana, aimed at expanding contract manufacturing and establishing a new advanced facility in Hyderabad. The move is expected to significantly boost the company’s global medicine supply.
Roche and KlinRisk have announced that they received a CE mark for the Kidney Klinrisk Algorithm, the first AI-based risk stratification tool for determining progressive decline in kidney function. The CE mark for the Kidney Klinrisk Algorithm...
Zydus Lifesciences has received final clearance from the USFDA for its Deflazacort Oral Suspension (22.75 mg/mL) for the treatment of Duchenne Muscular Dystrophy in patients aged 5 years and older, which is a generic version of Emflaza Oral...
Abbott, a global healthcare leader, has announced the launch of its AVEIR Dual Chamber (DR) leadless pacemaker system. It is the first dual-chamber leadless pacemaker system in the world that is engineered to help the heart beat in a more...
Eli Lilly and Company has revealed a substantial investment in India of up to $1 billion over the next few years to build new contract manufacturing facilities and a new advanced manufacturing and quality hub in Hyderabad. The US pharma company...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")